| __timestamp | Celldex Therapeutics, Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 7050000 |
| Thursday, January 1, 2015 | 100171000 | 8413000 |
| Friday, January 1, 2016 | 102726000 | 12038000 |
| Sunday, January 1, 2017 | 96171000 | 17900000 |
| Monday, January 1, 2018 | 66449000 | 15765000 |
| Tuesday, January 1, 2019 | 42672000 | 11140000 |
| Wednesday, January 1, 2020 | 42534000 | 11715000 |
| Friday, January 1, 2021 | 53311000 | 17344000 |
| Saturday, January 1, 2022 | 82258000 | 22829000 |
| Sunday, January 1, 2023 | 118011000 | 12665000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Celldex Therapeutics, Inc. and MiMedx Group, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Celldex consistently outspent MiMedx, with its R&D expenses peaking at nearly 180% higher than MiMedx's in 2023. This trend highlights Celldex's aggressive pursuit of innovation, particularly in the early years, where it spent over 14 times more than MiMedx in 2014. However, MiMedx has shown a steady increase in its R&D budget, culminating in a 224% rise from 2014 to 2022. This data underscores the strategic differences between the two companies, with Celldex focusing on high initial investment and MiMedx gradually ramping up its R&D efforts.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and MiMedx Group, Inc.
Analyzing R&D Budgets: Genmab A/S vs Celldex Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Alkermes plc vs MiMedx Group, Inc.
TG Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: CymaBay Therapeutics, Inc. vs MiMedx Group, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vericel Corporation and MiMedx Group, Inc.
Protagonist Therapeutics, Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Mesoblast Limited and Celldex Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Wave Life Sciences Ltd. and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Celldex Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.